Axel Hauschild

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety

R Hofmann-Wellenhof, R. Hofmann-Wellenhof, J. Paoli, 2014, The British journal of dermatology.

Loss of leucocyte common antigen (CD45) on atypical lymphocytes in the localized but not disseminated type of Pagetoid reticulosis

A. Hauschild, W. Sterry, Axel Hauschild, 1991, The British journal of dermatology.

Adjuvant Therapy in Melanoma

M. Weichenthal, A. Hauschild, P. Mohr, 1998, Oncology Research and Treatment.

Actual practice of melanoma follow‐up and treatment in Germany: results of a prospective, longitudinal cohort study

A. Hauschild, D. Schadendorf, K. Kähler, 2015, The British journal of dermatology.

Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.

A. Lallas, V. del Marmol, B. Volkmer, 2024, European journal of cancer.

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.

C. Gebhardt, I. Heidrich, Glenn Geidel, 2024, European journal of cancer.

COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.

M. Mandalà, G. Long, P. Lorigan, 2023, Future oncology.

Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

A. Hauschild, Axel Hauschild, 2009, Current oncology.

Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: results of a German multicenter study.

A. Hauschild, D. Schadendorf, W. Stolz, 2000, Journal of Investigative Dermatology.

Immunotherapy of distant metastatic disease

A. Hauschild, D. Schadendorf, A. Eggermont, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.